Literature DB >> 17188352

Impact of visceral involvements and blood cell count abnormalities on survival in adult T-cell leukemia/lymphoma (ATLL).

Yumi Takasaki1, Masako Iwanaga, Kunihiro Tsukasaki, Miyuki Kusano, Kazuyuki Sugahara, Yasuaki Yamada, Shimeru Kamihira, Shuichi Ikeda, Masao Tomonaga.   

Abstract

Multiple visceral involvements and various blood cell count abnormalities are frequently manifested in adult T-cell leukemia/lymphoma (ATLL) at diagnosis. We evaluated the effects of four visceral involvement (bone marrow (BM), skin, liver, spleen) and six blood cell count abnormalities (anemia, neutrophilia, thrombocytopenia, monocytosis, eosinophilia, basophilia) on the overall survival of 168 ATLL patients. In the aggressive type, BM involvement, skin involvement and monocytosis were significantly poor prognostic factors. Furthermore, concomitant involvement of BM and additional visceral organs worsened the prognosis. These data support that multiple organ involvements represent a poor prognostic factor for ATLL and provide clinical significance for BM examinations.

Entities:  

Mesh:

Year:  2006        PMID: 17188352     DOI: 10.1016/j.leukres.2006.11.013

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  10 in total

Review 1.  Cancer-associated myeloproliferation: old association, new therapeutic target.

Authors:  Ryan A Wilcox
Journal:  Mayo Clin Proc       Date:  2010-07       Impact factor: 7.616

Review 2.  Proposed diagnostic criteria and classification of basophilic leukemias and related disorders.

Authors:  P Valent; K Sotlar; K Blatt; K Hartmann; A Reiter; I Sadovnik; W R Sperr; P Bettelheim; C Akin; K Bauer; T I George; E Hadzijusufovic; D Wolf; J Gotlib; F-X Mahon; D D Metcalfe; H-P Horny; M Arock
Journal:  Leukemia       Date:  2017-01-16       Impact factor: 11.528

Review 3.  Human T-cell leukemia virus-associated malignancy.

Authors:  Amanda R Panfil; Michael P Martinez; Lee Ratner; Patrick L Green
Journal:  Curr Opin Virol       Date:  2016-08-31       Impact factor: 7.090

4.  Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells.

Authors:  Ryan A Wilcox; David A Wada; Steven C Ziesmer; Sherine F Elsawa; Nneka I Comfere; Allan B Dietz; Anne J Novak; Thomas E Witzig; Andrew L Feldman; Mark R Pittelkow; Stephen M Ansell
Journal:  Blood       Date:  2009-08-11       Impact factor: 22.113

5.  Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting.

Authors:  Kunihiro Tsukasaki; Olivier Hermine; Ali Bazarbachi; Lee Ratner; Juan Carlos Ramos; William Harrington; Deirdre O'Mahony; John E Janik; Achiléa L Bittencourt; Graham P Taylor; Kazunari Yamaguchi; Atae Utsunomiya; Kensei Tobinai; Toshiki Watanabe
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

6.  The absolute monocyte and lymphocyte prognostic index for patients with diffuse large B-cell lymphoma who receive R-CHOP.

Authors:  Nicolas Batty; Elham Ghonimi; Lei Feng; Luis Fayad; Anas Younes; Maria Alma Rodriguez; Jorge Enrique Romaguera; Peter McLaughlin; Felipe Samaniego; Larry W Kwak; Fredrick B Hagemeister
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-11-06

Review 7.  Endobiogeny: a global approach to systems biology (part 2 of 2).

Authors:  Jean-Claude Lapraz; Kamyar M Hedayat; Patrice Pauly
Journal:  Glob Adv Health Med       Date:  2013-03

8.  Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis.

Authors:  Sally Temraz; Deborah Mukherji; Zein Al Abideen Farhat; Rami Nasr; Maya Charafeddine; Mohammed Shahait; Mohammad Rachad Wehbe; Rami Abou Ghaida; Ibrahim Abu Gheida; Ali Shamseddine
Journal:  BMC Urol       Date:  2014-09-19       Impact factor: 2.264

9.  Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.

Authors:  Huseini Kagdi; Maria Antonietta Demontis; Juan Carlos Ramos; Graham P Taylor
Journal:  PLoS Pathog       Date:  2018-02-14       Impact factor: 6.823

10.  Clinical Trials and Treatment of ATL.

Authors:  Kunihiro Tsukasaki; Kensei Tobinai
Journal:  Leuk Res Treatment       Date:  2012-01-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.